A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France

NCT03757013 · clinicaltrials.gov ↗

COMPLETED

Status

453

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Apremilast

Sponsor

Amgen